ENTITY
Lansen Pharmaceutical

Lansen Pharmaceutical (1LP GR)

25
Analysis
Health Care • China
Lansen Pharmaceutical Holdings Ltd. is an investment holding company engaged in the research, development, production, and sales of traditional Chinese and chemical medicines. It specializes in pharmaceuticals for rheumatology and dermatology, with key products including total glucosides of paeony capsules. The company also has segments for cosmetics and healthcare products. It was founded in 2001 and is headquartered in Ningbo, Zhejiang, China.
more
Exchange Announcement • 18 Dec 2023 08:12

Joint Announcement (1) Proposed Privatisation Of Lansen Pharmaceutical Holdings Limited By The Offeror By Way Of A Scheme Of Arrangement Under Section 86 Of The Companies Act; (2) Effective Date Of The Scheme; (3) Withdrawal Of Listing Of Lansen Pharmaceutical Holdings Limited; And (4) Despatch Of Cheques

Exchange Announcement • 15 Dec 2023 07:26

Joint Announcement (1) Proposed Privatisation Of Lansen Pharmaceutical Holdings Limited By The Offeror By Way Of A Scheme Of Arrangement Under Section 86 Of The Companies Act; (2) Proposed Withdrawal Of Listing Of Lansen Pharmaceutical Holdings Limited; (3) Results Of The Grand Court Hearing Of The Petition For The Sanction Of The Scheme; (4) Expected Effective Date Of The Scheme; And (5) Expected Withdrawal Of Listing Of The Shares

Exchange Announcement • 01 Dec 2023 17:20

Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 November 2023

Exchange Announcement • 27 Nov 2023 18:49

Joint Announcement (1) Proposed Privatisation Of Lansen Pharmaceutical Holdings Limited By The Offeror By Way Of A Scheme Of Arrangement Under Section 86 Of The Companies Act; (2) Proposed Withdrawal Of Listing Of Lansen Pharmaceutical Holdings Limited (3) Results Of The Court Meeting And The General Meeting; And (4) Closure Of Register Of Members Of Lansen Pharmaceutical Holdings Limited

Exchange Announcement • 01 Nov 2023 18:30

Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 October 2023

x